Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 76

    1.

    A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease.

    Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, Feyzi JM, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill JB, McMurray JJ, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto R; the TREAT Investigators.

    N Engl J Med. 2009 Nov 19;361(21):2019-2032. Epub 2009 Oct 30.PMID: 19880844 [PubMed - as supplied by publisher]Related articles

    2.

    Selecting among ADA/EASD tier 1 and tier 2 treatment options.

    McGill JB.

    J Fam Pract. 2009 Sep;58(9 Suppl Treating):S26-34. Review.PMID: 19744422 [PubMed - indexed for MEDLINE]Related articles

    3.

    Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study.

    Rosenstock J, Fonseca V, McGill JB, Riddle M, Hallé JP, Hramiak I, Johnston P, Davis M.

    Diabetologia. 2009 Sep;52(9):1971-3. Epub 2009 Jul 16. No abstract available. PMID: 19609501 [PubMed - in process]Related articlesFree article

    4.

    Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study.

    Rosenstock J, Fonseca V, McGill JB, Riddle M, Hallé JP, Hramiak I, Johnston P, Davis M.

    Diabetologia. 2009 Sep;52(9):1778-88. Epub 2009 Jun 13.PMID: 19526210 [PubMed - in process]Related articlesFree article

    5.
    6.

    Improving microvascular outcomes in patients with diabetes through management of hypertension.

    McGill JB.

    Postgrad Med. 2009 Mar;121(2):89-101. Review.PMID: 19332966 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Progress and controversies: treating obesity and insulin resistance in the context of hypertension.

    McGill JB, Haffner S, Rees TJ, Sowers JR, Tershakovec AM, Weber M.

    J Clin Hypertens (Greenwich). 2009 Jan;11(1):36-41. Review.PMID: 19125857 [PubMed - indexed for MEDLINE]Related articles

    9.

    Demographic analyses of the effects of carvedilol vs metoprolol on glycemic control and insulin sensitivity in patients with type 2 diabetes and hypertension in the Glycemic Effects in Diabetes Mellitus: Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) study.

    Phillips RA, Fonseca V, Katholi RE, McGill JB, Messerli FH, Bell DS, Raskin P, Wright JT Jr, Iyengar M, Anderson KM, Lukas MA, Bakris GL; GEMINI Investigators.

    J Cardiometab Syndr. 2008 Fall;3(4):211-7.PMID: 19040589 [PubMed - indexed for MEDLINE]Related articles

    10.

    Comparison of carvedilol and metoprolol on serum lipid concentration in diabetic hypertensive patients.

    Bell DS, Bakris GL, McGill JB.

    Diabetes Obes Metab. 2009 Mar;11(3):234-8. Epub 2008 Jun 17.PMID: 18564334 [PubMed - indexed for MEDLINE]Related articles

    11.

    How to make exercise counseling more effective: lessons from rural America.

    Weidinger KA, Lovegreen SL, Elliott MB, Hagood L, Haire-Joshu D, McGill JB, Brownson RC.

    J Fam Pract. 2008 Jun;57(6):394-402.PMID: 18544323 [PubMed - indexed for MEDLINE]Related articles

    12.

    Inpatient glycemic control on the vascular surgery service.

    Theilen BM, Gritzke KA, Knutsen PG, Riek AE, McGill JB, Sicard GA, Tobin GS.

    Endocr Pract. 2008 Mar;14(2):185-91.PMID: 18308656 [PubMed - indexed for MEDLINE]Related articles

    13.

    The changing landscape of type 2 diabetes: the role of incretin-based therapies in managed care outcomes.

    Triplitt C, McGill JB, Porte D Jr, Conner CS.

    J Manag Care Pharm. 2007 Dec;13(9 Suppl C):S2-16; quiz S17. Review.PMID: 18062735 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    The decrease in microalbuminuria with carvedilol therapy is not enhanced by concurrent use of a statin.

    Bell DS, McGill JB, Fonseca VA.

    Endocr Pract. 2007 Nov-Dec;13(7):808-9. No abstract available. PMID: 18194941 [PubMed - indexed for MEDLINE]Related articles

    15.

    Effect of LDL cholesterol and treatment with losartan on end-stage renal disease in the RENAAL study.

    Tershakovec AM, Keane WF, Zhang Z, Lyle PA, Appel GB, McGill JB, Parving HH, Cooper ME, Shahinfar S, Brenner BM.

    Diabetes Care. 2008 Mar;31(3):445-7. Epub 2007 Dec 10.PMID: 18070995 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    How the diabetic eye loses vision.

    Davidson JA, Ciulla TA, McGill JB, Kles KA, Anderson PW.

    Endocrine. 2007 Aug;32(1):107-16. Epub 2007 Sep 27. Review.PMID: 17992608 [PubMed - indexed for MEDLINE]Related articles

    17.

    Lowering blood pressure with beta-blockers in combination with other renin-angiotensin system blockers in patients with hypertension and type 2 diabetes: results from the GEMINI Trial.

    Wright JT Jr, Bakris GL, Bell DS, Fonseca V, Katholi RE, McGill JB, Messerli FH, Phillips RA, Raskin P, Holdbrook FK, Lukas MA, Iyengar M.

    J Clin Hypertens (Greenwich). 2007 Nov;9(11):842-9.PMID: 17978591 [PubMed - indexed for MEDLINE]Related articles

    18.

    Psychosocial factors in patients with chronic kidney disease.

    Weisbord SD, McGill JB, Kimmel PL.

    Adv Chronic Kidney Dis. 2007 Oct;14(4):316-8. No abstract available. PMID: 17904497 [PubMed - indexed for MEDLINE]Related articles

    19.

    Effects of pyridoxamine in combined phase 2 studies of patients with type 1 and type 2 diabetes and overt nephropathy.

    Williams ME, Bolton WK, Khalifah RG, Degenhardt TP, Schotzinger RJ, McGill JB.

    Am J Nephrol. 2007;27(6):605-14. Epub 2007 Sep 6.PMID: 17823506 [PubMed - indexed for MEDLINE]Related articles

    20.

    Kidney outcomes in long-term studies of ruboxistaurin for diabetic eye disease.

    Tuttle KR, McGill JB, Haney DJ, Lin TE, Anderson PW; PKC-DRS, PKC-DMES, and PKC-DRS 2 Study Groups.

    Clin J Am Soc Nephrol. 2007 Jul;2(4):631-6. Epub 2007 May 30.PMID: 17699475 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL study.

    Keane WF, Zhang Z, Lyle PA, Cooper ME, de Zeeuw D, Grunfeld JP, Lash JP, McGill JB, Mitch WE, Remuzzi G, Shahinfar S, Snapinn SM, Toto R, Brenner BM; RENAAL Study Investigators.

    Clin J Am Soc Nephrol. 2006 Jul;1(4):761-7. Epub 2006 May 17.PMID: 17699284 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Protein kinase C beta inhibition: the promise for treatment of diabetic nephropathy.

    Anderson PW, McGill JB, Tuttle KR.

    Curr Opin Nephrol Hypertens. 2007 Sep;16(5):397-402. Review.PMID: 17693752 [PubMed - indexed for MEDLINE]Related articles

    23.

    Body weight changes with beta-blocker use: results from GEMINI.

    Messerli FH, Bell DS, Fonseca V, Katholi RE, McGill JB, Phillips RA, Raskin P, Wright JT Jr, Bangalore S, Holdbrook FK, Lukas MA, Anderson KM, Bakris GL; GEMINI Investigators.

    Am J Med. 2007 Jul;120(7):610-5.PMID: 17602935 [PubMed - indexed for MEDLINE]Related articles

    24.

    Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP).

    McCullough PA, Jurkovitz CT, Pergola PE, McGill JB, Brown WW, Collins AJ, Chen SC, Li S, Singh A, Norris KC, Klag MJ, Bakris GL; for the KEEP Investigators.

    Arch Intern Med. 2007 Jun 11;167(11):1122-9.PMID: 17563019 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Continued use of an integrated meter with electronic logbook maintains improvements in glycemic control beyond a randomized, controlled trial.

    Laffel LM, Hsu WC, McGill JB, Meneghini L, Volkening LK.

    Diabetes Technol Ther. 2007 Jun;9(3):254-64.PMID: 17561796 [PubMed - indexed for MEDLINE]Related articles

    26.

    Differential effect of beta-blocker therapy on insulin resistance as a function of insulin sensitizer use: results from GEMINI.

    Fonseca V, Bakris GL, Bell DS, McGill JB, Raskin P, Messerli FH, Phillips RA, Katholi RE, Wright JT Jr, Waterhouse B, Lukas MA, Anderson KM; for the GEMINI Investigators.

    Diabet Med. 2007 Jul;24(7):759-63. Epub 2007 Apr 19.PMID: 17451422 [PubMed - indexed for MEDLINE]Related articles

    27.

    Efficacy of sertraline in prevention of depression recurrence in older versus younger adults with diabetes.

    Williams MM, Clouse RE, Nix BD, Rubin EH, Sayuk GS, McGill JB, Gelenberg AJ, Ciechanowski PS, Hirsch IB, Lustman PJ.

    Diabetes Care. 2007 Apr;30(4):801-6.PMID: 17392541 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    beta-blocker use and diabetes symptom score: results from the GEMINI study.

    McGill JB, Bakris GL, Fonseca V, Raskin P, Messerli FH, Phillips RA, Katholi RE, Wright JT Jr, Iyengar M, Anderson KM, Lukas MA, Dalal MR, Bell DS.

    Diabetes Obes Metab. 2007 May;9(3):408-17.PMID: 17391169 [PubMed - indexed for MEDLINE]Related articles

    29.

    Effect of ruboxistaurin on urinary transforming growth factor-beta in patients with diabetic nephropathy and type 2 diabetes.

    Gilbert RE, Kim SA, Tuttle KR, Bakris GL, Toto RD, McGill JB, Haney DJ, Kelly DJ, Anderson PW.

    Diabetes Care. 2007 Apr;30(4):995-6. Epub 2007 Jan 17. No abstract available. PMID: 17229944 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Epidemiology of obesity and chronic kidney disease.

    Ross WR, McGill JB.

    Adv Chronic Kidney Dis. 2006 Oct;13(4):325-35. Review.PMID: 17045219 [PubMed - indexed for MEDLINE]Related articles

    31.

    Clinical safety of the selective PKC-beta inhibitor, ruboxistaurin.

    McGill JB, King GL, Berg PH, Price KL, Kles KA, Bastyr EJ, Hyslop DL.

    Expert Opin Drug Saf. 2006 Nov;5(6):835-45. Review.PMID: 17044810 [PubMed - indexed for MEDLINE]Related articles

    32.

    Anemia and the role of erythropoietin in diabetes.

    McGill JB, Bell DS.

    J Diabetes Complications. 2006 Jul-Aug;20(4):262-72. Review.PMID: 16798479 [PubMed - indexed for MEDLINE]Related articles

    33.

    Alterations in left ventricular structure and function in type-1 diabetics: a focus on left atrial contribution to function.

    Peterson LR, Waggoner AD, de las Fuentes L, Schechtman KB, McGill JB, Gropler RJ, Dávila-Román VG.

    J Am Soc Echocardiogr. 2006 Jun;19(6):749-55.PMID: 16762752 [PubMed - indexed for MEDLINE]Related articles

    34.

    Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial.

    Lustman PJ, Clouse RE, Nix BD, Freedland KE, Rubin EH, McGill JB, Williams MM, Gelenberg AJ, Ciechanowski PS, Hirsch IB.

    Arch Gen Psychiatry. 2006 May;63(5):521-9.PMID: 16651509 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Increased myocardial fatty acid metabolism in patients with type 1 diabetes mellitus.

    Herrero P, Peterson LR, McGill JB, Matthew S, Lesniak D, Dence C, Gropler RJ.

    J Am Coll Cardiol. 2006 Feb 7;47(3):598-604. Epub 2006 Jan 18.PMID: 16458143 [PubMed - indexed for MEDLINE]Related articles

    36.

    Paradoxical increase in ventricular torsion and systolic torsion rate in type I diabetic patients under tight glycemic control.

    Chung J, Abraszewski P, Yu X, Liu W, Krainik AJ, Ashford M, Caruthers SD, McGill JB, Wickline SA.

    J Am Coll Cardiol. 2006 Jan 17;47(2):384-90. Epub 2005 Dec 20.PMID: 16412865 [PubMed - indexed for MEDLINE]Related articles

    37.

    Differential effects of beta-blockers on albuminuria in patients with type 2 diabetes.

    Bakris GL, Fonseca V, Katholi RE, McGill JB, Messerli F, Phillips RA, Raskin P, Wright JT Jr, Waterhouse B, Lukas MA, Anderson KM, Bell DS; GEMINI Investigators.

    Hypertension. 2005 Dec;46(6):1309-15. Epub 2005 Nov 14.PMID: 16286578 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    A multilevel ecological approach to promoting walking in rural communities.

    Brownson RC, Hagood L, Lovegreen SL, Britton B, Caito NM, Elliott MB, Emery J, Haire-Joshu D, Hicks D, Johnson B, McGill JB, Morton S, Rhodes G, Thurman T, Tune D.

    Prev Med. 2005 Nov-Dec;41(5-6):837-42. Epub 2005 Oct 26.PMID: 16256183 [PubMed - indexed for MEDLINE]Related articles

    39.

    The effect of ruboxistaurin on nephropathy in type 2 diabetes.

    Tuttle KR, Bakris GL, Toto RD, McGill JB, Hu K, Anderson PW.

    Diabetes Care. 2005 Nov;28(11):2686-90.PMID: 16249540 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    The effects of plasma insulin and glucose on myocardial blood flow in patients with type 1 diabetes mellitus.

    Srinivasan M, Herrero P, McGill JB, Bennik J, Heere B, Lesniak D, Davila-Roman VG, Gropler RJ.

    J Am Coll Cardiol. 2005 Jul 5;46(1):42-8.PMID: 15992633 [PubMed - indexed for MEDLINE]Related articles

    41.

    Rationale--Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): evolving the management of cardiovascular risk in patients with chronic kidney disease.

    Mix TC, Brenner RM, Cooper ME, de Zeeuw D, Ivanovich P, Levey AS, McGill JB, McMurray JJ, Parfrey PS, Parving HH, Pereira BJ, Remuzzi G, Singh AK, Solomon SD, Stehman-Breen C, Toto RD, Pfeffer MA.

    Am Heart J. 2005 Mar;149(3):408-13. Erratum in: Am Heart J. 2005 Jul;150(1):53. PMID: 15864229 [PubMed - indexed for MEDLINE]Related articles

    42.

    Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.

    Bakris GL, Fonseca V, Katholi RE, McGill JB, Messerli FH, Phillips RA, Raskin P, Wright JT Jr, Oakes R, Lukas MA, Anderson KM, Bell DS; GEMINI Investigators.

    JAMA. 2004 Nov 10;292(18):2227-36.PMID: 15536109 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Circulating 1,5-anhydroglucitol levels in adult patients with diabetes reflect longitudinal changes of glycemia: a U.S. trial of the GlycoMark assay.

    McGill JB, Cole TG, Nowatzke W, Houghton S, Ammirati EB, Gautille T, Sarno MJ; U.S. trial of the GlycoMark assay.

    Diabetes Care. 2004 Aug;27(8):1859-65.PMID: 15277408 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Kidney Early Evaluation Program (KEEP). Findings from a community screening program.

    McGill JB, Brown WW, Chen SC, Collins AJ, Gannon MR.

    Diabetes Educ. 2004 Mar-Apr;30(2):196-8, 200-2, 206. Review.PMID: 15095511 [PubMed - indexed for MEDLINE]Related articles

    45.

    Lack of effect of sucralose on glucose homeostasis in subjects with type 2 diabetes.

    Grotz VL, Henry RR, McGill JB, Prince MJ, Shamoon H, Trout JR, Pi-Sunyer FX.

    J Am Diet Assoc. 2003 Dec;103(12):1607-12.PMID: 14647086 [PubMed - indexed for MEDLINE]Related articles

    46.

    Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study.

    Raskin P, Bode BW, Marks JB, Hirsch IB, Weinstein RL, McGill JB, Peterson GE, Mudaliar SR, Reinhardt RR.

    Diabetes Care. 2003 Sep;26(9):2598-603.PMID: 12941725 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Serum 1,5-anhydroglucitol (GlycoMark ): a short-term glycemic marker.

    Buse JB, Freeman JL, Edelman SV, Jovanovic L, McGill JB.

    Diabetes Technol Ther. 2003;5(3):355-63.PMID: 12828817 [PubMed - indexed for MEDLINE]Related articles

    48.

    Depression and coronary heart disease in women with diabetes.

    Clouse RE, Lustman PJ, Freedland KE, Griffith LS, McGill JB, Carney RM.

    Psychosom Med. 2003 May-Jun;65(3):376-83.PMID: 12764210 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Fat-free foods supplemented with soy stanol-lecithin powder reduce cholesterol absorption and LDL cholesterol.

    Spilburg CA, Goldberg AC, McGill JB, Stenson WF, Racette SB, Bateman J, McPherson TB, Ostlund RE Jr.

    J Am Diet Assoc. 2003 May;103(5):577-81.PMID: 12728215 [PubMed - indexed for MEDLINE]Related articles

    50.

    Anxiety and poor glycemic control: a meta-analytic review of the literature.

    Anderson RJ, Grigsby AB, Freedland KE, de Groot M, McGill JB, Clouse RE, Lustman PJ.

    Int J Psychiatry Med. 2002;32(3):235-47. Review.PMID: 12489699 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...